Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Anticipate generic drug launch
Proactively manage your pharmacy inventory
Manage your formulary budget
Drug patents …
… from Kazakhstan to Kalamazoo
Find generic entry opportunities
|Title:||Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B|
|Abstract:||Use of a compound of formula (I) or a pharmaceutically acceptable derivative thereof in the manufacture of a medicament for the treatment of hepatitis B is disclosed. ##STR1##|
|Inventor(s):||Belleau, deceased; Bernard (late of Westmont, CA), Nguyen-Ba; Nghe (La Prairie, CA)|
|Assignee:||BioChem Pharma, Inc. (Laval, CA)|
Patent Claim Types:|
see list of patent claims
|Use; Dosage form;|
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|United Kingdom||9100039||Jan 03, 1991|
|United Kingdom||9109913||May 07, 1991|
|PCT Filed||January 03, 1992||PCT Application Number:||PCT/CA92/00001|
|PCT Publication Date:||July 23, 1992||PCT Publication Number:||WO92/11852|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.